Copyright
©The Author(s) 2025.
World J Nephrol. Jun 25, 2025; 14(2): 103923
Published online Jun 25, 2025. doi: 10.5527/wjn.v14.i2.103923
Published online Jun 25, 2025. doi: 10.5527/wjn.v14.i2.103923
Table 1 5-year and 10-year overall survival
Variable (n = 79367) | Academic (n = 30780) | Non-academic (n = 48587) | P value |
5-year OS (%) | 17.0 | 11.5 | < 0.05 |
10-year OS (%) | 9.20 | 5.50 | < 0.05 |
- Citation: Weng B, Braaten M, Lehn J, Morrissey R, Asghar MS, Silberstein P, Abdul Jabbar AB, Mathews A, Tauseef A, Mirza M. Survival and treatment of stage IV renal cell carcinoma in academic vs non-academic medical centers. World J Nephrol 2025; 14(2): 103923
- URL: https://www.wjgnet.com/2220-6124/full/v14/i2/103923.htm
- DOI: https://dx.doi.org/10.5527/wjn.v14.i2.103923